Skip to content

Evaluation of the effect of inhaled budesonide (Pulmicort) on children with acute asthma attack

Evaluation of the effect of inhaled budesonide (Pulmicort) on children with acute asthma attack in patients referred to Ali Asghar Children's Hospital

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190106042260N2
Enrollment
80
Registered
2020-06-02
Start date
2020-03-20
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute asthma attack in pediatric. Asthma

Interventions

Intervention 1: Intervention group: Children with an acute asthma attack receive the basic treatment for an asthma attack and will also receive an inhaled budesonide (Pulmicort). Ventolin dose will be

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: Diagnosed as asthma by doctor Lack of other chronic and specific diseases Diagnosis as acute asthma attack by doctor Age range Between 2-12 years old

Exclusion criteria

Exclusion criteria: A child with heart disease Lack of willingness to participate in the study Have chronic lung disease other than asthma Children who have received specific steroid medications over the past 7 days

Design outcomes

Primary

MeasureTime frame
Cough rate. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on mild / moderate / severe.;Weezing score. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on a score of 0 to 3/ without, in inhalation, in exhalation, Both.;Workup Breathing. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on mild / moderate / severe.;Duration of hospitalization. Timepoint: The number of hospitalization days. Method of measurement: According to the number of days.;Respiratory rate. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on mild / moderate / severe.;Possible complication. Timepoint: During the hospitalisation. Method of measurement: Based on drug side effects.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRozhin Pahlevani

Iran University of Medical Sciences

rozhin.pahlevan@gmail.com+98 21 4431 9829

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026